Volume 14, Issue 6 (6-2016)                   IJRM 2016, 14(6): 411-420 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nateghi Rostami M, Hossein Rashidi B. Comparison of clinical performance of antigen basedenzyme immunoassay (EIA) and major outer membrane protein (MOMP)-PCR for detection of genital Chlamydia trachomatis infection. IJRM. 2016; 14 (6) :411-420
URL: http://journals.ssu.ac.ir/ijrmnew/article-1-762-en.html
1- Department of Microbiology and Immunology, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran , Rostami52@yahoo.com
2- Department of Obstetrics and Gynecology, Vali-Asr Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran
Abstract:   (1200 Views)
Background: Chlamydia trachomatis is the most common sexually transmitted bacterial pathogen worldwide. Early detection and treatment of C.trachomatis genital infection prevent serious reproductive complications.
Objective: Performances of enzyme immunoassay (EIA) and major outer membrane protein (MOMP)-polymerase chain reaction (PCR) for diagnosis of genital C.trachomatis infection in women were compared.
Materials and Methods: In this cross sectional study a total of 518 women volunteers were included (33.67±8.3 yrs) who had been referred to Gynecology clinics of Qom province, Iran, were included. Endocervical swab specimens were collected to detect lipopolysaccharide (LPS) antigen in EIA and to amplify MOMP gene of C.trachomatis in PCR. Results were confirmed using ompI nested-PCR. Sensitivity, specificity, positive (PPV) and negative predictive values (NPV) were calculated for performance of the tests. Odds ratios were determined using binary logistic regression analysis.
Results: In total, 37 (7.14%) cases were positive by EIA and/or MOMP-PCR. All discrepant results were confirmed by nested-PCR. Sensitivity, specificity, PPV and NPV values of EIA were 59.46%, 100%, 100% and 96.98%, and those of MOMP-PCR were 97.30%, 100%, 100%, 99.79%, respectively. Reproductive complications including 2.7% ectopic pregnancy, 5.4% stillbirth, 5.4% infertility, and 10.8% PROM were recorded. The risk of developing chlamydiosis was increased 4.8-fold in volunteers with cervicitis (p<0.05; OR 4.80; 95% CI 1.25-18.48).
Conclusion: C.trachomatis infection should be regarded in women of reproductive ages especially those with cervicitis. Primary screening of women by using the low cost antigen-EIA is recommended; however, due to the low sensitivity of Ag-EIA, verification of the negative results by a DNA amplification method is needed.
Full-Text [PDF 407 kb]   (205 Downloads) |   |   Full-Text (HTML)  (128 Views)  
Type of Study: Original Article |

References
1. Sexually transmitted infections (STIs) [database on the Internet]. World Health Organization. Available at: http://www.who.int/mediacentre/factsheets/fs110/ en/.
2. Da Ros CT, Schmitt Cda S. Global epidemiology of sexually transmitted diseases. Asian J Androl 2008; 10: 110-114. [DOI:10.1111/j.1745-7262.2008.00367.x]
3. Kassaian N, Ataei B, Yaran M, Babak A, Shoaei P, Ataie M. HIV and other sexually transmitted infections in women with illegal social behavior in Isfahan, Iran. Adv Biomed Res 2012; 1: 5. [DOI:10.4103/2277-9175.94427]
4. Salerno J, Darling-Fisher C, Hawkins NM, Fraker E. Identifying relationships between high-risk sexual behaviors and screening positive for chlamydia and gonorrhea in school-wide screening events. J Sch Health 2013; 83: 99-104. [DOI:10.1111/josh.12004]
5. Voisin DR, Salazar LF, Crosby R, Diclemente RJ. The relationship between ethnic identity and Chlamydia and Gonorrhea infections among low-income detained African American adolescent females. Psychol Health Med 2013; 18: 355-362. [DOI:10.1080/13548506.2012.726361]
6. Masese L, Baeten JM, Richardson BA, Deya R, Kabare E, Bukusi E, et al. Incidence and correlates of Chlamydia trachomatis infection in a high-risk cohort of Kenyan women. Sex Transm Dis 2013; 40: 221-225. [DOI:10.1097/OLQ.0b013e318272fe45]
7. Al-Thani A, Abdul-Rahim H, Alabsi E, Bsaisu HN, Haddad P, Mumtaz GR, et al. Prevalence of Chlamydia trachomatis infection in the general population of women in Qatar. Sex Transm Infect 2013; 89 (Suppl.): 57-60. [DOI:10.1136/sextrans-2013-051169]
8. Rashidi BH, Chamani-Tabriz L, Haghollahi F, Jeddi-Tehrani M, Naghizadeh MM, Shariat M, et al. Effects of Chlamydia trachomatis Infection on Fertility; A Case-Control Study. J Reprod Infertil 2013; 14: 67-72.
9. Price MJ, Ades AE, De Angelis D, Welton NJ, Macleod J, Soldan K, et al. Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model. Am J Epidemiol. 2013; 178: 484-492. [DOI:10.1093/aje/kws583]
10. Land JA, Gijsen AP, Kessels AG, Slobbe ME, Bruggeman CA. Performance of five serological chlamydia antibody tests in subfertile women. Hum Reprod 2003; 18: 2621-2627. [DOI:10.1093/humrep/deg479]
11. Baud D, Regan L, Greub G. Comparison of five commercial serological tests for the detection of anti-Chlamydia trachomatis antibodies. Eur J Clin Microbiol Infect Dis 2010; 29: 669-675. [DOI:10.1007/s10096-010-0912-4]
12. Palayekar VV, Joshi JV, Hazari KT, Shah RS, Chitlange SM. Comparison of four nonculture diagnostic tests for Chlamydia trachomatis infection. J Assoc Physicians India 2000; 48: 481-483.
13. Van Dyck E, Ieven M, Pattyn S, Van Damme L, Laga M. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests. J Clin Microbiol 2001; 39: 1751-1756. [DOI:10.1128/JCM.39.5.1751-1756.2001]
14. El Qouqa IA, Shubair ME, Al Jarousha AM, Sharif FA. Prevalence of Chlamydia trachomatis among women attending gynecology and infertility clinics in Gaza, Palestine. Int J Infect Dis 2009; 13: 334-341. [DOI:10.1016/j.ijid.2008.07.013]
15. Thomas BJ, Pierpoint T, Taylor-Robinson D, Renton AM. Quantification of Chlamydia trachomatis in cervical and urine specimens from women attending a genitourinary medicine clinic: implications for screening strategies. Int J STD AIDS 1998; 9: 448-451. [DOI:10.1258/0956462981922601]
16. Malenie R, Joshi PJ, Mathur MD. Chlamydia trachomatis antigen detection in pregnancy and its verification by antibody blocking assay. Indian J Med Microbiol 2006; 24: 97-100. [DOI:10.4103/0255-0857.25179]
17. Leszczynska-Gorzelak B, Darmochwal-Kolarz D, Borowiec-Blinowska A, Oleszczuk J. The prevalence of Chlamydia trachomatis infection in pregnant women. Med Wieku Rozwoj 2005; 9: 27-35.
18. Kuipers JG, Scharmann K, Wollenhaupt J, Nettelnbreker E, Hopf S, Zeidler H. Sensitivities of PCR, MicroTrak, ChlamydiaEIA, IDEIA, and PACE 2 for purified Chlamydia trachomatis elementary bodies in urine, peripheral blood, peripheral blood leukocytes, and synovial fluid. J Clin Microbiol. 1995; 33: 3186-3190.
19. Harindra V, Underhill G, Tobin JM. Screening for genital chlamydia infection: DNA amplification techniques should be the test of choice. Int J STD AIDS 2003; 14: 723-726. [DOI:10.1258/09564620360719732]
20. Watson EJ, Templeton A, Russell I, Paavonen J, Mardh PA, Stary A, et al. The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. J Med Microbiol 2002; 51: 1021-1031. [DOI:10.1099/0022-1317-51-12-1021]
21. Tanaka M, Nakayama H, Yoshida H, Takahashi K, Nagafuji T, Hagiwara T, et al. Detection of Chlamydia trachomatis in vaginal specimens from female commercial sex workers using a new improved enzyme immunoassay. Sex Transm Infect 1998; 74: 435-438. [DOI:10.1136/sti.74.6.435]
22. Macmillan S, McKenzie H, Templeton A. Parallel observation of four methods for screening women under 25 years of age for genital infection with Chlamydia trachomatis. Eur J Obstet Gynecol Reprod Biol 2003; 107: 68-73. [DOI:10.1016/S0301-2115(02)00266-X]
23. Ngeow YF, Hema V, Zakaria M, Lee CH, Ramachandran S. Detection of Chlamydia trachomatis in urine samples by polymerase chain reaction and enzyme immunoassay. Malays J Pathol 1997; 19: 127-132.
24. Chan EL, Brandt K, Stoneham H, Antonishyn N, Horsman GB. Comparison of the effectiveness of polymerase chain reaction and enzyme immunoassay in detecting Chlamydia trachomatis in different female genitourinary specimens. Arch Pathol Lab Med 2000; 124: 840-843.
25. Hajikhani B, Motallebi T, Norouzi J, Bahador A, Bagheri R, Asgari S, et al. Classical and molecular methods for evaluation of Chlamydia trachomatis infection in women with tubal factor infertility. J Reprod Infertil 2013; 14: 29-33.
26. Hashemi FB, Pourakbari B, Yazdi JZ. Frequency of Chlamydia trachomatis in women with cervicitis in Tehran, Iran. Infect Dis Obstet Gynecol 2009; 2009: 67014.
27. Fatholahzadeh B, Bahador A, Haghighi Hasanabad M, Bazarjani F, Haghighi F. Comparative screening of Chlamydia trachomatis infection in women population in Tehran, Iran. Iran Red Crescent Med J 2012; 14: 289-293.
28. Chamani-Tabriz L, Tehrani MJ, Akhondi MM, Mosavi-Jarrahi A, Zeraati H, Ghasemi J, et al. Chlamydia trachomatis prevalence in Iranian women attending obstetrics and gynaecology clinics. Pak J Biol Sci 2007; 10: 4490-4494. [DOI:10.3923/pjbs.2007.4490.4494]
29. Haghighi Hasanabad M, Mohammadzadeh M, Bahador A, Fazel N, Rakhshani H, Majnooni A. Prevalence of Chlamydia trachomatis and Mycoplasma genitalium in pregnant women of Sabzevar-Iran. Iran J Microbiol 2011; 3: 123-128.
30. Yeganeh O, Jeddi-Tehrani M, Yaghmaie F, Kamali K, Heidari-Vala H, Zeraati H, et al. A survey on the prevalence of Chlamydia trachomatis and Mycoplasma genitalium infections in symptomatic and asymptomatic men referring to urology clinic of Labbafinejad hospital, Tehran, Iran. Iran Red Crescent Med J 2013; 15: 340-344. [DOI:10.5812/ircmj.8600]
31. Ghazvini K, Ahmadnia H, Ghanaat J. Frequency of Chlamydia trachomatis among male patients with urethritis in northeast of Iran detected by polymerase chain reaction. Saudi J Kidney Dis Transpl 2012; 23: 316-320.
32. Ghanaat J, Afshari JT, Ghazvini K, Malvandi M. Prevalence of genital Chlamydia in Iranian males with urethritis attending clinics in Mashhad. East Mediterr Health J 2008; 14: 1333- 1337.
33. Kose S, Ersan G, Serin Sender S, Devrim I, Inal MM. A prevalence study of Chlamydia infections in Turkish population. Braz J Infect Dis 2013; 17: 114-115. [DOI:10.1016/j.bjid.2012.07.020]
34. Eksi F, Dikensoy E, Gayyurhan ED, Balci I, Balat O, Karsligil T, et al. The prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae in the endocervical swab specimens of symptomatic, asymptomatic and infertile women in Turkey. Arch Gynecol Obstet 2011; 283: 1349-1355. [DOI:10.1007/s00404-010-1694-8]
35. Alzahrani AJ, Obeid OE, Hassan MI, Almulhim AA. Screening of pregnant women attending the antenatal care clinic of a tertiary hospital in eastern Saudi Arabia for Chlamydia trachomatis and Neisseria gonorrhoeae infections. Indian J Sex Trans Dis 2010; 31: 81-86. [DOI:10.4103/0253-7184.74976]
36. Khan MS, Unemo M, Zaman S, Lundborg CS. Health-seeking behaviour of women selling sex in Lahore, Pakistan. Int J STD AIDS 2011; 22: 376-380. [DOI:10.1258/ijsa.2011.010375]
37. Abdul-Karim ET, Abdul-Muhymen N, Al-Saadie M. Chlamydia trachomatis and rubella antibodies in women with full-term deliveries and women with abortion in Baghdad. East Mediterr Health J 2009; 15: 1407-1411.
38. Berntsson M, Tunback P. Clinical and microscopic signs of cervicitis and urethritis: correlation with Chlamydia trachomatis infection in female STI patients. Acta Derm Venereol 2013; 93: 230-233. [DOI:10.2340/00015555-1536]
39. Menon S, Timms P, Allan JA, Alexander K, Rombauts L, Horner P, et al. Human and pathogen factors associated with Chlamydia trachomatis-related infertility in women. Clin Microbiol Rev 2015; 28: 969-985. [DOI:10.1128/CMR.00035-15]

Send email to the article author


© 2021 All Rights Reserved | International Journal of Reproductive BioMedicine

Designed & Developed by : Yektaweb